Innovative Short Term Debt from 2010 to 2024
| 002173 Stock | 8.89 0.18 2.07% |
Short Term Debt | First Reported 2010-12-31 | Previous Quarter 247.2 M | Current Value 152.6 M | Quarterly Volatility 105 M |
Check Innovative Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Innovative Medical's main balance sheet or income statement drivers, such as Interest Expense of 4.2 M, Selling General Administrative of 40.6 M or Total Revenue of 550.5 M, as well as many indicators such as . Innovative financial statements analysis is a perfect complement when working with Innovative Medical Valuation or Volatility modules.
Innovative | Short Term Debt |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Innovative Stock
Innovative Medical financial ratios help investors to determine whether Innovative Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Innovative with respect to the benefits of owning Innovative Medical security.